Prostate Cancer
Discovery of a Highly Potent PROTAC Degrader of p300/CBP Proteins for the Treatment of Enzalutamide-Resistant Prostate Cancer.
October 10, 2024
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy vs. IMRT for Localized Prostate Cancer.
October 10, 2024
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
October 9, 2024
Plant-based diets and urological health.
October 9, 2024
Quantitative MRI biomarker for classification of clinically significant prostate cancer: Calibration for reproducibility across echo times.
October 9, 2024
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
October 9, 2024
Deep Learning Features Can Improve Radiomics-Based Prostate Cancer Aggressiveness Prediction.
October 9, 2024
Synthetic Lethal Targeting of Cyclin Dependent Kinase-12-Deficient Prostate Cancer with PARP Inhibitors.
October 9, 2024
Rediscovering citrate as a biomarker for prostate cancer.
October 9, 2024
Unusual Prostate-Specific Membrane Antigen (PSMA) Splenic Uptake in a Patient With Prostate Cancer.
October 8, 2024
Prostate cancer survivorship of Australian men living with prostate cancer: Patient support programs in Australia.
October 8, 2024
Location-based Radiology Report-Guided Semi-supervised Learning for Prostate Cancer Detection.
October 8, 2024